PubChem

See the following -

3Rs For Innovating Novel Antibiotics: Sharing Resources, Risks, And Rewards

Anthony D So, Quentin Ruiz-Esparza, Neha Gupta, Otto Cars | BMJ | April 3, 2012

The stream of new antibiotics is struggling to keep up with emerging bacterial resistance. Anthony So and colleagues examine what can be done to increase innovation... Read More »

Molecular Craigslist

mattoddchem | Intermolecular | April 19, 2012

I think we need an eBay for molecules. Or maybe a Craigslist. Read More »

We Cannot Do Modern Science Unless It's Open

Open is about sharing and collaboration. It's the idea that "we" is more powerful, more rewarding and fulfilling than "I". I can't promise jobs, but I do know that open is becoming very big. Governments and funders are pushing the open agenda, even though academics are generally uninterested or seriously self-interested... Read More »

Why Open Drug Discovery Needs Four Simple Rules For Licensing Data And Models

Antony J. Williams, John Wilbanks, and Sean Ekins | PLoS Computational Biology | September 27, 2012

As we see a future of increased database integration, the licensing of the data may be a hurdle that hampers progress and usability. We have formulated four rules for licensing data for open drug discovery, which we propose as a starting point for consideration by databases and for their ultimate adoption. Read More »